Shots:

• ZOLL Medical to acquire all outstanding ordinary shares of Itamar Medical for $31/ADS or $1.03/ordinary share in cash making a total deal value of $538M representing a premium of 50.2% for $31/ADS to the stock’s last closing price on Sept 10- 2021. The transaction is expected to close at the end of 2021
• The acquisition will combine Itamar’s WatchPAT technology and digital health solution with ZOLL Medical to advance home sleep therapy for patients with sleep apnea
• Itamar’s WatchPAT technology is an innovative sleep apnea diagnosis program for patients and healthcare professionals. The device is FDA-cleared- safe and effective method for home-based testing for sleep apnea

  | Ref: Businesswire | Image: Businesswire